glp-1 drugs alternative Supplements: Experts Weigh in on 'Natural Ozempic' Boom The GLP-1 Natural Alternative: What

FDA-approved semaglutide products (Ozempic, Wegovy, Rybelsus) are commercially available

Semaglutide was approved in 2017 as Ozempic for diabetes, and in 2021 as Wegovy for obesity

How this compares to Lilly and Novo Nordisk

Compared with SGLT-2 inhibitor use, GLP-1 receptor agonist use was not associated with an increased risk of pulmonary aspiration (pooled risk ratio 0.98, 95% CI 0.73 to 1.31), although it was associated with a higher risk for discontinuation of endoscopy (1.99, 1.56 to 2.53)

Prediction: Eli Lilly's Newest GLP-1 Drug Will Be a Game-Changer for the Stock

Studies found that the semaglutide pill works about as well for weight loss as the injectable version of semaglutide